I
Inventys Research
A research-driven Custom Chemicals Manufacturing Company
About Inventys Research
Inventys Research Company, founded in 2005, specializes in the manufacturing of intermediates, actives, and specialty chemicals. The company operates in the chemical and pharmaceutical sectors, serving innovators and businesses requiring complex chemical synthesis. Inventys employs advanced technologies to ensure innovative, cost-effective, and safe processes. The company is certified with WHO GMP, ISO9001, ISO14001, and ISO45001, reflecting its commitment to quality and safety standards. Inventys has a robust internal R&D, engineering, process automation, and HSEQ (Health, Safety, Environment, and Quality) capabilities. The business model focuses on Contract Development and Manufacturing Organization (CDMO) services, advancing molecules from discovery to manufacturing. Revenue is generated through the production and sale of Key Starting Materials (KSMs), Advanced Intermediates, and Active Pharmaceutical Ingredients (APIs) in both non-GMP and GMP grades. The company employs over 300 people and conducts more than 200 training sessions monthly to ensure continuous improvement and excellence.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2006
- Headquarters
- Mumbai, India
- Employees
- 253
- Open positions
- None listed
- Dealroom signal
- 22.7/100
- Industry
- Chemicals
- Sector
- Chemicals, Horticultural Products, Hard Tech
- Business model
- Manufacturing
- Client focus
- b2b
- Links
- Website
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VC✓Equity / VC | Apr 2021 | $31M | $125M | Plutus Wealth Management | ↗ |
Growth signals
Latest recorded traffic for Inventys Research is 1.3K monthly website visits, down 38.1% over the last three months. Inventys Research's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later1 investor entered at this stage
Plutus Wealth Management
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Inventys Research on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Inventys Research’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.